Share on StockTwits

Affymetrix (NASDAQ:AFFX) is scheduled to post its quarterly earnings results on Wednesday, February 5th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Affymetrix (NASDAQ:AFFX) opened at 8.72 on Tuesday. Affymetrix has a 52 week low of $3.22 and a 52 week high of $9.80. The stock’s 50-day moving average is $8.92 and its 200-day moving average is $6.94. The company’s market cap is $627.1 million.

A number of research firms have recently commented on AFFX. Analysts at Maxim Group raised their price target on shares of Affymetrix from $9.00 to $11.00 in a research note to investors on Tuesday, January 7th. They now have a “buy” rating on the stock. On the ratings front, analysts at Morgan Stanley downgraded shares of Affymetrix from an “equal weight” rating to an “underweight” rating in a research note to investors on Monday, January 6th. They now have a $7.20 price target on the stock. Finally, analysts at Zacks reiterated an “outperform” rating on shares of Affymetrix in a research note to investors on Monday, December 2nd. They now have a $10.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $8.53.

Affymetrix, Inc (NASDAQ:AFFX) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.